CLA reduces breast cancer cell growth and invasion through ERα and PI3K/Akt pathways

被引:29
|
作者
Bocca, C. [1 ]
Bozzo, F. [1 ]
Cannito, S. [1 ]
Colombatto, S. [1 ]
Miglietta, A. [1 ]
机构
[1] Univ Turin, Dept Expt Med & Oncol, I-10125 Turin, Italy
关键词
CLA; MCF-7; MDA-MB-231; ER alpha; PI3K/Akt; beta-Catenin/E-cadherin; CONJUGATED LINOLEIC-ACID; PROTEIN PHOSPHATASE 2A; SIGNALING PATHWAY; ESTROGEN-RECEPTOR; BETA-CATENIN; MCF-7; CELLS; DNA-BINDING; PPAR-GAMMA; KINASE; PHOSPHORYLATION;
D O I
10.1016/j.cbi.2009.09.022
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We previously reported that conjugated linoleic acid (CIA), a naturally occurring fatty acid, inhibits the growth of ER alpha(+) MCF-7 and ER alpha(-) MDA-MB-231 human breast cancer cells by negative modulation of the ERK/MAPK pathway and apoptosis induction. Here we show that in these cell lines CIA also down-regulates the PI3K/Akt cascade. In MCF-7 cells CLA also triggers ER alpha/PP2A complex formation reducing the phosphorylation state and transcriptional activity of Era whereas in MDA-MB-231 cells CIA does not induce PP2A activation. Moreover, CLA induces the expression of proteins involved in cell adhesion and inhibits cell migration and MMP-2 activity. These findings suggest that CIA may induce the down-regulation of ERa signalling and the reduction of cell invasion through the modulation of balancing between phosphatases and kinases. (C) 2009 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:187 / 193
页数:7
相关论文
共 50 条
  • [1] Src may be involved in the anti-cancer effect of conjugated linoleic acid. Comment on: CIA reduces breast cancer cell growth and invasion through ER and PI3K/Akt pathways
    Chen, Jiezhong
    CHEMICO-BIOLOGICAL INTERACTIONS, 2010, 186 (02) : 250 - 251
  • [2] Plantamajoside Reduces Gastric Cancer Cell Migration and Invasion by Inhibiting PI3K/AKT and ERK Pathways
    Tang, Chenglu
    Wang, Yuanyuan
    Huang, Jing
    Lv, Xiaohong
    CURRENT TOPICS IN NUTRACEUTICAL RESEARCH, 2023, 21 (02) : 175 - 181
  • [3] Breast Cancer Invasion and Metastasis by mPRα Through the PI3K/Akt Signaling Pathway
    Wu, Xiaojuan
    Sun, Limin
    Wang, Xiao
    Su, Peng
    Li, Zhishuang
    Zhang, Chunyan
    Wang, Yan
    Gao, Peng
    Ma, Rong
    PATHOLOGY & ONCOLOGY RESEARCH, 2016, 22 (03) : 471 - 476
  • [4] Everolimus inhibits breast cancer cell growth through PI3K/AKT/mTOR signaling pathway
    Du, Liyan
    Li, Xiaomei
    Zhen, Linhong
    Chen, Weiling
    Mu, Lingguang
    Zhang, Yang
    Song, Ailin
    MOLECULAR MEDICINE REPORTS, 2018, 17 (05) : 7163 - 7169
  • [5] EGF induces EMT through PI3K/Akt and MAPK singnaling pathways in breast cancer cell lines
    Kim, Jin Kyoung
    Kong, Jienan
    Lee, Youngseok
    Jeong, Hoiseon
    Kim, Aeree
    CANCER RESEARCH, 2012, 72
  • [6] CRYAB inhibits migration and invasion of bladder cancer cells through the PI3K/AKT and ERK pathways
    Ruan, Houxin
    Li, Yang
    Wang, Xu
    Sun, Bin
    Fang, Weihua
    Jiang, Shan
    Liang, Chaozhao
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2020, 50 (03) : 254 - 260
  • [7] Drugging the PI3K/AKT/mTOR Pathway in ER plus Breast Cancer
    Alves, Carla L.
    Ditzel, Henrik J.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (05)
  • [8] Piceatannol Suppresses Breast Cancer Cell Invasion through the Inhibition of MMP-9: Involvement of PI3K/AKT and NF-κB Pathways
    Ko, Hyun Suk
    Lee, Hyo-Jeong
    Kim, Sung-Hoon
    Lee, Eun-Ok
    JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 2012, 60 (16) : 4083 - 4089
  • [9] Carvacrol Alleviates Prostate Cancer Cell Proliferation, Migration, and Invasion through Regulation of PI3K/Akt and MAPK Signaling Pathways
    Luo, Yun
    Wu, Jie-Ying
    Lu, Min-Hua
    Shi, Zhi
    Na, Ning
    Di, Jin-Ming
    OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, 2016, 2016
  • [10] Curcumol inhibits breast cancer growth via NCL/ERα36 and the PI3K/AKT pathway
    Wei, Zhou Lu
    Juan, Wang
    Tong, Dou
    Juan, Li Xiao
    Sa, Liu Yi
    Jie, Huang Fu Meng
    Xiao, Guan
    Xiang, Liu Guo
    Jie, Han Meng
    Xu, Chen
    FOOD & FUNCTION, 2023, 14 (02) : 874 - 885